News Releases

Year

11 December 2020

Cronos Group Inc. to Present at the MKM Partners Virtual Conference

TORONTO , Dec. 11, 2020 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein, Executive Chairman, will present at The Road Ahead, Preparation for 2021: MKM Partners Virtual

25 November 2020

Cronos Group Inc. to Speak at the Cowen 2020 Boston Cannabis Conference

TORONTO , Nov. 25, 2020 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein, Executive Chairman, is scheduled to speak on a panel at the Cowen 2020 Boston Cannabis

13 November 2020

Cronos Group Inc. to Present at the Jefferies Virtual West Coast Consumer Conference

TORONTO , Nov. 13, 2020 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein, Executive Chairman, will speak at the Jefferies Virtual West Coast Consumer Conference on

05 November 2020

Cronos Group Reports 2020 Third Quarter Results

Kurt Schmidt appointed President and CEO; Mike Gorenstein appointed Executive Chairman Launched a new hemp-derived CBD brand, Happy Dance ™, in the U.S. market in partnership with Kristen Bell Cronos Israel received approval to sell PEACE NATURALS ™ branded pre-rolls and oils in Israel Cronos

23 October 2020

Cronos Group Inc. to Hold 2020 Third Quarter Earnings Conference Call on November 5, 2020

TORONTO , Oct. 23, 2020 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) will hold its 2020 Third Quarter Earnings Conference Call on Thursday, November 5, 2020 at 8:30 a.m. EST . Cronos Group’s senior management team will discuss the Company’s

14 October 2020

Kristen Bell Launches Happy Dance™ CBD Brand with Cronos Group

New CBD skincare collection redefines self-care TORONTO and LOS ANGELES , Oct. 14, 2020 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) today announced the launch of Happy Dance™, a new, clean, simple CBD skincare brand, co-founded with actress and

05 October 2020

Cronos Group launches leading medical brand PEACE NATURALS™ in Israel

TORONTO and GAN SHMUEL , Israel , Oct. 05, 2020 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) a global cannabinoid company, is pleased to announce the launch of its leading medical brand PEACE NATURALS™, in pharmacies throughout Israel through

15 September 2020

Cronos Group Recognized by the Toronto Stock Exchange’s TSX30 Program

TORONTO , Sept. 15, 2020 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) today announced that on September 15, 2020 , the Company was recognized by the Toronto Stock Exchange as the third top-performing company on the Toronto Stock Exchange’s 2020

14 September 2020

Cronos Group Inc. to Present at the CIBC 19th Annual Eastern Institutional Investor Conference

TORONTO , Sept. 14, 2020 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein, Executive Chairman, will speak at the CIBC 19th Annual Eastern Institutional Investor

09 September 2020

Cronos Group Announces Expanded Leadership Structure to Drive Next Phase of Growth

30-Year CPG Executive Kurt Schmidt Joins Cronos as Chief Executive Officer and Mike Gorenstein Named Executive Chairman TORONTO , Sept. 09, 2020 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) today announced that its Board of Directors has

06 August 2020

Cronos Group Reports 2020 Second Quarter Results

Cronos Israel commenced the sale of PEACE NATURALS™ products to the Israeli medical cannabis market Natuera completed three additional test exports of hemp-derived CBD extract to the U.S. for business development and R&D purposes Successfully implemented a new enterprise resource planning system

09 July 2020

Cronos Group Announces Completion of Continuance to British Columbia

TORONTO , July 09, 2020 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) announces that, effective today, the Company has continued from the laws of the Province of Ontario to the laws of the Province of British Columbia (the “Continuance”).The

06 July 2020

Cronos Group Inc. to Hold 2020 Second Quarter Earnings Conference Call on August 6, 2020

TORONTO , July 06, 2020 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) will hold its 2020 Second Quarter Earnings Conference Call on Thursday, August 6, 2020 at 8:30 a.m. EDT . Cronos Group’s senior management team will discuss the Company’s

25 June 2020

Cronos Group Inc. Announces Results of 2020 Annual and Special Meeting of Shareholders

TORONTO , June 25, 2020 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) announces that at its Annual and Special Meeting of Shareholders held earlier today (the “Meeting”) there were 652 shareholders voting in person or by proxy holding in total

29 May 2020

Cronos Group Inc. Announces Conference Participation for June 2020

TORONTO , May 29, 2020 (GLOBE NEWSWIRE) -- Cronos Group Inc. (“Cronos Group” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein, Chairman, President and Chief Executive Officer, will speak at two upcoming investor conferences: Piper Sandler 40th Annual

15 May 2020

Cronos Group Inc. to Hold Virtual 2020 Annual and Special Meeting of Shareholders

TORONTO , May 15, 2020 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) will hold its 2020 Annual and Special Meeting of Shareholders on Thursday, June 25, 2020 , at 10:00 a.m. EDT . Due to the continued public health concerns related to the

08 May 2020

Cronos Group Reports 2020 First Quarter Results

Fermented target cannabinoid, CBGA, using cannabinoid strains at Cronos Fermentation R&D labs Successfully completed first dried flower shipment to Israel , as Cronos Israel moves closer to entering the medical cannabis market with PEACE NATURALS™ branded products Natuera completes key

27 April 2020

Cronos Group Inc. to Hold 2020 First Quarter Earnings Conference Call on May 8, 2020

TORONTO , April 27, 2020 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) will hold its 2020 First Quarter Earnings Conference Call on Friday, May 8, 2020 at 8:30 a.m. EDT . Cronos Group’s senior management team will discuss the Company’s financial

30 March 2020

Cronos Group Reports 2019 Fourth Quarter and Full-Year Results

Completed Audit Committee Review and Restated Certain 2019 Unaudited Interim Financial Statements Expanded Canadian distribution to new provinces and product categories across the adult-use market Established Cronos Fermentation, a critical step in advancing the production of cultured cannabinoids

30 March 2020

Cronos Group Inc. to Report 2019 Fourth Quarter and Full-Year Financial Results on March 30, 2020

TORONTO , March 30, 2020 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) will report its 2019 Fourth Quarter and Full-Year Financial Results on Monday, March 30, 2020 after the close of trading on NASDAQ.

17 March 2020

Cronos Group to Restate Certain 2019 Unaudited Interim Financial Statements

TORONTO , March 17, 2020 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) announced today that the Company determined, on the recommendation of the Audit Committee of the Company’s Board of Directors and after consultation with KPMG LLP , the

02 March 2020

Cronos Group Files Form 12b-25

TORONTO , March 02, 2020 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) today announced that it has filed a Form 12b-25 with the U.S. Securities and Exchange Commission , providing the Company a 15-day extension of the due date for filing its

24 February 2020

Cronos Group to Delay 2019 Fourth Quarter and Full-Year Earnings Release and Conference Call

TORONTO , Feb. 24, 2020 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) today announced that it will delay its 2019 fourth quarter and full-year earnings release and conference call, previously scheduled for Thursday, February 27, 2020 .

28 January 2020

Cronos Group Inc. to Hold 2019 Fourth Quarter and Full-Year Conference Call on February 27, 2020

TORONTO , Jan. 28, 2020 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) will hold its 2019 Fourth Quarter and Full-Year Earnings Conference Call on Thursday, February 27, 2020 at 8:30 a.m. EST . Cronos Group’s senior management team will discuss

23 January 2020

Cronos Group Inc. CEO, Mike Gorenstein, to Speak at the 23rd Annual CIBC Western Institutional Investor Conference

TORONTO , Jan. 23, 2020 (GLOBE NEWSWIRE) -- Cronos Group Inc. (“Cronos Group” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein , Chairman, President and Chief Executive Officer, will speak at the 23rd Annual CIBC Western Institutional Investor

07 January 2020

Cronos Group Inc. CEO, Mike Gorenstein, to Present at The ICR Conference 2020

TORONTO , Jan. 07, 2020 (GLOBE NEWSWIRE) -- Cronos Group Inc. (“Cronos Group” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein , Chairman, President and Chief Executive Officer, will speak at the ICR Conference 2020 on January 14, 2020 at 9:00 a.m.